Geron

4 followers

‌

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Industries

Biotechnology, Health & Wellness

Headquarters

Menlo Park, United States

Employees

201-500

Links

Org chart

John A. Scarlett

Chairman, President & CEO

John A. Scarlett

Collapse

Andrew J. Grethlein

EVP & COO

Edward Koval

EVP & Chief Business Officer

Michelle Robertson

Executive Vice President, CFO & Treasurer

Melissa A. Kelly Behrs

EVP, Business Operations & Chief Alliance Officer

Faye Feller

EVP, Chief Medical Officer

Jim Ziegler

EVP & Chief Commercial Officer

Scott A. Samuels

EVP, CLO & Corporate Secretary

Nishan Sengupta

Vice President-market Access, Pricing, Evidence Strategy

Scott Hutson

Vice President Of Sales

Ryan Vincenti

Associate Director Of Commercial Excellence

Teams

+16

Directors

19 members

+11

Clinical Operations Team

14 members

Medical and Clinical Teams

11 members

Leadership Team

5 members

Business Operations Team

6 members

Human Resources Team

6 members

Offices

Similar companies

Roivant Sciences

56 followers

Cytokinetics

12 followers

Schrödinger

8 followers

ElevateBio

5 followers

Axsome Therapeutics

4 followers

Iovance Biotherapeutics

4 followers

BridgeBio

3 followers

Vir Biotechnology

3 followers

Nurix

3 followers

Tonal

19 followers

Viz

8 followers

Explore companies